Synergist Medical Management Introduces Breakthrough Affordable Genetic Cancer Testing For Early Intervention And Prevention

Share Article

Hereditary Cancer Screening Can Save Lives

Genetic testing for cancer can now be ordered along with an annual wellness checkup through a family physician. Synergist Medical Management has just introduced an affordable hereditary cancer screening test that private practice physicians can offer to their patients as a regular part of routine wellness care.

The day has arrived when genetic screening for the major cancers is possible on a widespread level at an affordable cost. Synergist's hereditary cancer screening includes 30-panel testing that identifies markers for eight genetic cancers. These cancers include breast, prostate, ovarian, pancreatic, melanoma and others. The maximum estimated out of pocket expense for patients is an incredibly reasonable $249, versus the historical cost of $2,000 to $3,000 from other companies.

According to the National Cancer Institute (NCI), up to 10 percent of all cancers can be linked to an inherited gene mutation. For these patients, genetic cancer screening can now make the difference between worrying and proactive wellness planning. In the case of breast cancer, the average individual carries a 12.3 percent risk while individuals who test positive for the BRCA1 and BRCA2 gene mutations have an increased risk of developing breast cancer of up to 76 percent; hence the reason for hereditary cancer screening.

The NCI states that patients with a known family or personal history of increased cancer risk will represent the first priority group to undergo optional genetic cancer screening. While it is not always possible to rule out shared lifestyle traits or habits as a root cause for cancer, there are some hallmarks to look for that can suggest a higher risk of hereditary cancer. For example, in cases where the cancer develops early in life, appears in several close blood relatives, recurs multiple times in different forms in a single individual, is a rarer type of cancer or is known to occur more frequently in the patient's particular ethnic group or gender, genetic cancer screening is strongly recommended.

About Synergist: Synergist Medical Management provides innovative solutions to physicians nationwide. Current services include blood allergy testing, carrier testing, general and advanced blood work, radiology and imaging, toxicology, specialty pharmacy, pharmacogenetics and now, hereditary cancer screening.
http://www.synergistmedicalmanagement.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Landon Arnold
Thela Media Group LLC
+1 5125721800 Ext: 101
Email >